• fetus;
  • infant;
  • mother;
  • nutrition;
  • micronutrients;
  • pregnancy


  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

This review paper highlights mechanisms for nutritional regulation of maternal health and fetal development. Malnutrition (nutrient deficiencies or obesity) in pregnant women adversely affects their health by causing or exacerbating a plethora of problems, such as anaemia, maternal haemorrhage, insulin resistance, and hypertensive disorders (e.g. pre-eclampsia/eclampsia). Maternal malnutrition during gestation also impairs embryonic and fetal growth and development, resulting in deleterious outcomes, including intrauterine growth restriction (IUGR), low birthweight, preterm birth, and birth defects (e.g. neural tube defects and iodine deficiency disorders). IUGR and preterm birth contribute to high rates of neonatal morbidity and mortality. Major common mechanisms responsible for malnutrition-induced IUGR and preterm birth include: (i) abnormal growth and development of the placenta; (ii) impaired placental transfer of nutrients from mother to fetus; (iii) endocrine disorders; and (iv) disturbances in normal metabolic processes. Activation of a series of physiological responses leading to premature and sustained contraction of the uterine myometrium also results in preterm birth. Recent epidemiologic studies have suggested a link between IUGR and chronic metabolic disease in children and adults, and the effects of IUGR may be carried forward to subsequent generations through epigenetics. While advanced medical therapies, which are generally unavailable in low-income countries, are required to support preterm and IUGR infants, optimal nutrition during pregnancy may help ameliorate many of these problems. Future studies are necessary to develop effective nutritional interventions to enhance fetal growth and development and alleviate the burden of maternal morbidity and mortality in low- and middle-income countries.

Multiple genetic and environmental factors, including maternal nutrition, regulate fetal survival, growth and development.1,2 Studies with animal models have demonstrated that fetal growth and development is most vulnerable to maternal nutrient deficiencies in early gestation, specifically during the peri-implantation period and the period of rapid placental development.3 Neural tube defects, cretinism, intrauterine growth restriction (IUGR), and preterm birth are well-known adverse outcomes of general and specific nutrient deficiencies in human pregnancy.1 In addition to effects on fetal development, maternal malnutrition contributes to poor maternal health as well as high rates of morbidity and mortality. For example, maternal stunting, the result of chronic malnutrition during childhood, increases the risk of obstructed labour and obstetric fistula.4 Calcium deficiency is a risk factor for hypertensive disorders of pregnancy,1 while anaemia may increase the risk of maternal mortality because of haemorrhage.5,6

In October 2010, the United Nations Food and Agriculture Organization reported that 925 million people worldwide, including a large proportion of women of reproductive age, suffered from hunger; nearly all of the undernourished reside in low- and middle-income countries.7 Deficiencies of protein, vitamin A, iron, zinc, folate, and other micronutrients remain major nutritional problems in poor regions of the world.8–10 Fetal undernutrition can occur in adolescent pregnancies because of competition between the fetus and the mother for nutrients. Low birthweight and preterm delivery are twice as common and neonatal mortality is almost three-times higher in adolescent pregnancies than in adult pregnancies.2,10 Furthermore, suboptimal nutrition may result from short interpregnancy intervals (<18 months) which are associated with miscarriage, IUGR and preterm delivery.11,12

While maternal undernutrition has substantial implications for maternal and fetal health, overweight and obesity in pregnancy similarly increase the risk of poor health outcomes.13 Maternal obesity or overnutrition before or during pregnancy may result in IUGR and increased risk of neonatal mortality and morbidity, as well as adverse maternal health including insulin resistance, maternal haemorrhage, and hyperglycaemia.13,14 Currently one billion adults, worldwide, are overweight and more than 300 million are obese.1 Given the increasing epidemic of overweight and obesity in low-, middle- and high-income nations, overnutrition has emerged as a major public health problem globally.13

Over the past two decades, compelling epidemiological studies have linked both over- and undernutrition in pregnancy with maternal, fetal, and infant morbidity and mortality.1 Additionally, substantial evidence links IUGR with the aetiology of many chronic diseases in adult humans.15 These findings have prompted extensive animal studies to identify the biological mechanisms for nutritional regulation of fetal growth and development as well as long-term health consequences of IUGR, preterm birth, and other poor pregnancy outcomes.16–21 This paper highlights the recent advances in this area of biomedical research, with a focus on effects of macronutrients and micronutrients on adverse pregnancy outcomes, including maternal morbidity and mortality, infant morbidity and mortality, as well as fetal and infant growth and development. Specifically, our work focuses on nutritional needs for fetal growth and development, consequences of maternal malnutrition on maternal and fetal health outcomes, implications of IUGR, and future research priorities. Furthermore, we provide an overview of the biological mechanisms of nutritional needs in pregnancy, while the other papers contained within this supplement summarise the effects of specific nutrition interventions on maternal, newborn, and child health outcomes.

Nutritional needs for fetal growth and development

  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

Macronutrients required for fetal growth and development

Energy [primarily as adenosine triphosphate (ATP)] is required for a variety of physiological processes in the fetus, including nutrient transport, cell motility, and synthetic pathways.22 Dietary macronutrients are the ultimate sources of energy substrates during fetal growth although the specific sources of substrates for ATP production in the conceptus are cell- and tissue-specific. In pregnant women and the developing fetuses, glucose is the major fuel for red blood cells, brain, retinal cells, and kidney medulla cells, while the maternal and fetal hearts utilise both glucose and lactate. The small intestine of both the mother and the fetus oxidises the amino acids glutamate, aspartate, and glutamine to provide most energy requirements of these tissues.21 Through β-oxidation, fatty acids are the major energy substrates for the maternal liver, skeletal muscle, heart and kidneys. The fetal liver also oxidises long-chain fatty acids (LCFA) to CO2 at relatively high rates. Thus, a balanced and adequate supply of carbohydrates, lipids and proteins is critical to meet fetal and maternal needs for energy. In the next sections we discuss the contributions of each of the macronutrients in more detail.


Glucose is a major energy substrate for the mother and the developing fetus. Glucose is also the predominant source of reduced nicotinamide adenine dinucleotide phosphate (NADPH), which is an essential cofactor for antioxidative enzymes and diverse metabolic pathways in all cell types.22 Thus, a deficiency of glucose will immediately result in neurological dysfunction and disorders of the circulatory system. The metabolic functions of glucose to maintain whole-body homeostasis cannot be served by any other nutrient. Fetal glucose is primarily derived from the uptake of maternal glucose by the placenta.23 The fetal liver and kidney synthesise only a small amount of glucose from gluconeogenic amino acids.23 Dietary starch is the primary source of glucose for the mother (Table 1). In the post-absorptive state or in response to starvation or undernutrition, pregnant women mobilise glucose from (1) glycogen stores in the liver and muscle; (2) glycerol from lipolysis in adipose tissue; and (3) amino acids released by skeletal muscle.22 However, sole dependence of these mechanisms to provide glucose in the maternal circulation will cause maternal wasting.

Table 1.  Needs of macronutrients for maternal health and fetal growth and development
 Uptake by the fetusAction on fetal growth and developmentConsequences of insufficiency in pregnancy
  • a

    Complex carbohydrates for enteral nutrition (starch, glycogen and fibre) and simple carbohydrate for parenteral nutrition (glucose).

  • b

    PUFA that cannot be synthesised de novo by mother and fetus are linoleic acid (18:2ω6) and α-linolenic acid (18:3ω3); PUFA that cannot be adequately synthesised by mother and fetus from preformed precursors include arachidonic acid (20:4ω6), eicosapentaenoic acid (20:5ω3), and docosahexaenoic acid (20:6ω3); MUFA that can be adequately synthesised by mother and fetus include palmitoleic acid (16:1ω7), cis-vaccenic acid (18:1ω7), and oleic acid (18:1ω9); saturated LCFA that can be adequately synthesised by mother and fetus include palmitic acid (16:0), stearic acid (18:0), and arachidic acid (20:0); short-chain fatty acids include butyrate, propionate, and acetate.

  • c

    EAA that cannot be synthesised by mother and fetus are histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine; amino acids that are inadequately synthesised by gestating mother and her fetus include arginine and glutamine; NEAA that can be synthesised presumably in adequate amounts by mother and fetus include alanine, asparagine, aspartate, cysteine, glutamate, glycine, proline, serine, taurine, and tyrosine.28,29

  • ATP, adenosine triphosphate; EAA, essential amino acids; EFA, essential fatty acids (n-3 and n-6 PUFA); LCFA, long-chain fatty acids; MUFA, monounsaturated fatty acids; NADPH, nicotinamide adenine dinucleotide phosphate; NO, nitric oxide; PUFA, polyunsaturated fatty acids.

CarbohydratesaGlucose from (1) hydrolysis of maternal dietary starch; (2) glycogen from diet as well as stores in liver and muscle; (3) glycerol from lipolysis in adipose tissue; and (4) amino acids from protein degradation. Maternal glucose is transferred to fetus via the placenta.A major energy substrate for mother and fetus; the exclusive source of ATP for red blood cells; the predominant source of NADPH via the pentose cycle for NO and superoxide synthesis, one-carbon-unit metabolism, production of pregnancy hormones, and antioxidative reactions.Neurological damage; ketosis; fetal growth retardation; maternal weight loss; impaired blood flow; weakness; fatigue; reduced intestinal motility in both mother and fetus; suboptimal health of the colon in mother.
LipidsbSaturated and monounsaturated fatty acids can be synthesised from glucose and amino acids in mother and fetus; fetus accumulates relatively small amounts of lipids before gestation week 25, but relatively large amounts thereafter; EFA must be supplied through maternal diet; placenta is permeable to long-chain PUFA and can transport EFA from mother to fetus.Long-chain PUFA maintain membrane fluidity and permeability; serve as metabolic fuels for liver, skeletal muscle and heart; are important for retinal and neural development; act as bioactive signalling molecules; play an important role in the absorption of lipid-soluble vitamins by the small intestine.Maternal weight loss; hyperglycaemia; deficiency of EFA can detrimentally impair the growth and development of fetal organs (including the brain, eyes, and heart); deficiencies of lipid-soluble vitamins.
ProteincSome amino acids can be synthesised from EAA via inter-organ metabolism; multiple amino acid transport systems in the uterus and placenta; uptake of glutamine, glutamate, and other amino acids by fetus through swallowing of amniotic fluid (enteral nutrition).Amino acids are the building blocks of proteins and peptides; precursors for the synthesis of nitrogenous hormones; substrates for the production of numerous substances, including DNA, neurotransmitters, vasodilators, and signalling molecules; major metabolic fuels for the small intestine and cells of the immune system; contribute substantially to fetal growth.Neurological damage; anaemia; fetal growth retardation; maternal weight loss; impaired blood flow; weakness; fatigue; reduced intestinal motility; intestinal atrophy; kidney dysfunction; cardiac failure; oxidative stress.

The human placenta is permeable to LCFA and transfers them to the fetus for metabolic utilisation.24 Liver, skeletal muscle, and heart in the mother and the fetus depend on LCFA as major metabolic fuels. Conversely, short-chain fatty acids are the primary energy sources for colonocytes. Prior to 25 weeks of gestation, the human fetus accumulates only a small amount of lipids. After 25 weeks of pregnancy, the fetus exponentially accumulates a relatively large amount of lipids.24 Placental and fetal tissues are able to synthesise the ω9 (oleic acid) family of unsaturated fatty acids. However, humans cannot synthesise the ω6 or ω3 fatty acids, linoleic acid and α-linolenic acid. Therefore, these two unsaturated fatty acids must be provided in the diet to synthesise the long-chain ω-6 and ω-3 polyunsaturated fatty acids (PUFA; Table 1). Physiologically and nutritionally important long-chain ω-6 and ω-3 PUFA include arachidonic acid (20:4ω6), eicosapentaenoic acid (EPA 20:5ω3), and docosahexaenoic acid (DHA 20:6ω3) (Table 1). Beyond serving as an energy source, long-chain PUFA play an important role in maintaining the fluidity, permeability and conformation of cell membranes. They are also precursors for the synthesis of bioactive lipid molecules, including prostaglandins, thromboxanes and leukotrienes.24 Additionally, some long-chain PUFA (e.g. DHA) are regulators of eicosanoid metabolism and the synthesis of nitric oxide (NO), a signalling molecule and a neurotransmitter in multiple tissues, including the brain).25,26 Among PUFA, DHA has received the most attention over the past decade for its role in development. DHA modulates appropriate neuronal sheath mylenation and differentiation of neural stem cells to neurons and promotes the development of the brain, nerves, retinal photoreceptors, and the immune system in the fetus.27–30 However, rates of the synthesis of DHA from α-linolenic acid in the human placenta and fetal brain are low relative to the needs of DHA by the rapidly growing fetus.24


Amino acids serve not only as building blocks for proteins but also as essential precursors for the synthesis of a variety of physiologically important molecules, including hormones, neurotransmitters, NO, creatine, glutathione, carnitine and polyamines.31,32 Additionally, through multiple cell signalling pathways, amino acids regulate key metabolic pathways that are vital to human health, growth, development and reproduction.33 Based on nitrogen balance and growth, amino acids are traditionally classified as either nutritionally essential or nonessential (Table 1). However, the classification of nutritionally nonessential amino acids (NEAA) has conceptual limitations because there is no compelling evidence that certain NEAA (e.g. arginine and glutamine) can be adequately synthesised by the mother or fetus to support optimal fetal growth and development.33–35 The synthesis of fetal proteins depends on the balanced provision of all the constituent amino acids, namely both nutritionally essential amino acids (EAA) and NEAA. To meet the needs for amino acids by the developing fetus, pregnant women should consume diets containing adequate amounts of high-quality proteins. Because most staple grains are deficient in several EAA (e.g. lysine, methionine, threonine and tryptophan), the consumption of animal source foods is recommended.36 Vegetarian and vegan women must carefully balance their intakes of grains, legumes, and other sources of protein to ensure they meet their EAA requirements; when this is not possible, supplements with specific amino acids will be needed to ensure adequate EAA intakes.


Nutritionally significant micro-minerals cannot be synthesised by the body and, therefore, must be provided in the diet (Table 2). These inorganic nutrients are the backbone of the skeleton system, serve as second messengers in cell signalling, and maintain the polarity of the plasma membrane. Minerals also regulate extracellular and intracellular osmolality, which is important for maintaining cell and blood volume as well as cell viability and shape. Most minerals are either cofactors for enzymes or components of metallo proteins, and also participate in electron transport and redox reactions. The metabolic functions of the minerals are summarised in Table 2. We review those most commonly implicated in fetal and maternal health outcomes.

Table 2.  Nutritional needs of minerals for maternal health and fetal growth and development
 Rich dietary sourcesGeneral actionsSpecial importance during pregnancyConsequences of insufficiency in pregnancy
  1. ATP, adenosine triphosphate; ETS, electron transport system; IUGR, intrauterine growth restriction; PIH, pregnancy-induced hypertension; SOD, superoxide dismutase.

CalciumDairy foodsComponent of the bone; second messenger that regulates numerous biochemical pathways.Cell-to-cell adhesion; implantation; and placentationPIH, pre-eclampsia, eclampsia; preterm delivery
ChlorineMeat, dairy foods, saltPrincipal anion in the extracellular fluid; required for production of gastric acid; maintain a hydrated state of the mucus on epithelial cellsMaintenance of osmolality in blood protein digestionDisturbance of whole-body homeostasis; embryonic and fetal death
ChromiumMeat, vegetablesPotentiate insulin sensitivityGlucose transport; toxic at high intakeContributes to insulin resistance
CobaltMeatA component of vitamin B12One-carbon-unit metabolism; toxic at high intakeAnaemia, neurological disorders
CopperMeatFunction of mitochondrial ETS; cofactor of cytosolic Cu/Zn-SOD; regulation of iron and molybdenum absorption by the small intestineATP production in mitochondria; toxic at high intake and contribute to iron-deficiency anaemia and impairment of zinc absorptionWeakness, fatigue, impaired fetal growth and development
FluorineMeat, bonesA component of teethStrength of teeth; toxic at high levelsReduced fertility (animal studies)
IodineSea vegetables, seafood, iodised saltProduction of thyroid hormonesImportant for the proper development of central nervous system in fetusesIodine deficient disorders, including cretinism
IronMeat, legumes, fortified foodsOxygen binding, transport and storage; metabolism, generation of ATPStrain on maternal iron supply in pregnancy to meet maternal haemo-expansion; toxic at high intakeIron deficiency anaemia can increase risk of maternal haemorrhage; maternal mortality; preterm birth; IUGR
MagnesiumMeatRequired for glucose and protein metabolismATP production by red blood cells; cofactor for some ATP-dependent enzymesPre-eclampsia and preterm birth
ManganeseMeatRequired by Mn-dependent enzymes (including arginase and mitochondrial Mn-SOD)Ammonia detoxification by liver anti-oxidative reactionsNeurological damage, oxidative stress, and death
MolybdenumMeat, vegetablesComponent of molybdopterin, sulfite oxidase, and xanthine oxidoreductase; regulation of copper and iron absorptionToxic at high levels and contribution to iron-deficiency anaemia; prevention of copper toxicityIncrease of risk for copper toxicity; impaired metabolism of purines
NickelMeat, vegetablesCofactor for microbial enzymes (e.g. urease, glyoxylase, and Ni-SOD); required for microbial metabolism in the lumen of the intestineNormal microbial activity in the intestine; toxic at high levelsMaintenance of the normal microbiota in the intestine
PhosphorusMeat, dairy productsATP production, cell signalling, component of the boneEmbryonic survival; fetal growth and development energy metabolismWeakness; fatigue; embryonic and fetal death; IUGR
PotassiumMeat, dairy products, vegetablesMost abundant cation in intracellular fluidMaintenance of intracellular osmolality; function of the nerve and muscle; fetal growth and developmentCardiac arrest; weakness; fatigue; IUGR
SeleniumMeatCofactor for antioxidant enzymesProtect mother and fetus from oxidative stress; toxic at high levelsCardiac dysfunction; oxidative stress
SiliconMeat, vegetablesMediate association between cells and macromolecules (e.g. osteonectin); required for cartilage calcificationRequired for the growth of connective tissue and bones; toxic at high intakeAbnormal joint structure; soft-bone syndrome;
SodiumMeat, dairy products; saltPrincipal cation in extracellular fluid; sodium pump; nutrient transportMaintenance of extracellular osmolality; function of the nerve and muscle; fetal growth and developmentMalnutrition; multiple organ dysfunction; IUGR
SulfurMeat, milk, eggComponent of sulfur-containing amino acids metabolism of intestinal bacteriaInorganic sulfur cannot be used by mother or fetus; toxic at high levelsOxidative stress; IUGR
VanadiumMeat, vegetablesReact with H2O2 to form a pervanadate to stimulate phosphorylation of receptor proteins; potentiate insulin sensitivityCell signalling; glucose transportContribute to insulin resistance
ZincMeat, legumesGene expression; cofactor of cytosolic Zn/Cu-SOD; immune function; cell signallingFetal growth and development; regulation of food intake; impairment of copper absorption at high levelsMalnutrition; potential detrimental effect on immune function; IUGR

Calcium is a major component of the skeleton, cytoskeleton and teeth.37 Calcium-activated enzymes and calcium-binding proteins include pancreatic α-amylase, pancreatic phospholipases A2 and C, protein kinase C, phosphorylase kinase, calmodulin, troponin C, NO synthase, calcium-ATPase, and blood clotting proteins.38 Thus, calcium is required for digestion of dietary starch, blood clotting, intracellular proteolysis, cell-to-cell adhesion, and NO synthesis in nearly all cell types, including endothelial cells and uterus.39,40 Furthermore, calcium is a second messenger and in this role regulates uterine contraction. By maintaining the uterus in a quiescent state through an NO-dependent mechanism,40 calcium supplementation may modulate the risk of preterm labour.41

Iodine is an essential component of the thyroid hormones (triiodothyronine and thyroxine). Thyroid hormones regulate gene expression, energy metabolism, growth, development and reproduction.42 During fetal development, thyroid hormones are required for migration of radial neurons and appropriate neuronal mylenation. As discussed later and in the review in this supplement by Zimmermann,43 severe maternal iodine deficiency, which causes a hypothyroid condition, is associated with cretinism while milder forms of iodine deficiency can impair cognitive development in the infant. To meet the demand for thyroid hormone by the rapidly developing fetus, the recommended daily allowance for iodine increases by approximately 1/3 from 150 µg/day to 220 µg/day during pregnancy.44

Iron is the most abundant trace element in the body.45 It is a component of haeme and haeme proteins, including haemoglobin, myoglobin, and cytochromes. Iron is also required for the activities of non-haeme proteins. Thus, physiological levels of iron play important roles in: (1) oxygen binding, transport, storage, and sensing; (2) the metabolism of nutrients (including proteins, lipids, and glucose); (3) mitochondrial electron transport and ATP production; (4) DNA synthesis; (5) immunity; and (6) antioxidative reactions. A deficiency of iron can result in anaemia, hypoxia, increased risk for maternal mortality, as well as preterm birth and IUGR.46 Iron requirements almost double during pregnancy, namely from 15 mg/day to 27 mg/day.44 This increase is necessary to meet the iron requirements of the mother and the developing fetus as well as the haemodilution which occurs in the second and third trimesters. These increases in iron needs are partially compensated for by a progressive rise in iron absorption during pregnancy; however, the amounts that can be absorbed from even an optimal diet are less than the iron requirements in later pregnancy.6,47 Therefore, a woman must have adequate iron stores when entering pregnancy. This is unlikely for many women especially in developing countries, where 60% of pregnant women are anaemic.1

Magnesium has multiple metabolic functions. Magnesium, the second most abundant cation in cells, is a cofactor for many enzymes in multiple metabolic pathways, including glycolysis, the pentose cycle, the urea cycle, gluconeogenesis, purine and pyrimidine synthesis, fatty acid oxidation, and α-ketoacid decarboxylation.48 This mineral regulates nutrient metabolism, antioxidative reactions, signalling pathways, and ion channels. Notably, because magnesium promotes the relaxation of vascular smooth muscle cells and inhibits the contraction of the uterine myometrium, magnesium sulfate has long been used in treatment of pre-eclampsia, preterm labour, and preterm birth in clinical medicine.49

Zinc plays a key role in nutrient metabolism as well as the structures of DNA and protein.50 Although zinc is not directly involved in oxidation–reduction reactions, it tightly binds to proteins in cells. There are probably 100 zinc enzymes associated with the mammalian genome. Zinc-dependent enzymes and zinc-binding proteins include carbonic anhydrase, carboxypeptidases A and B, protein kinase C, phospholipase C, insulin, superoxide dismutase (cytosol), thymulin, and poly(ADP-ribose) polymerase. Thus, zinc plays an important role in regulating food intake, nutrient metabolism, DNA and protein synthesis, antioxidative reactions, neurological function, immunity, growth and development.51,52


Vitamins are required in small amounts as cofactors in biochemical reactions and classified into two types (water- or lipid-soluble) based on their solubility (Table 3). Water-soluble vitamins are absorbed by the small intestine into the portal circulation, whereas lipid-soluble vitamins can only be absorbed efficiently by the intestine into the lymph circulation when normal fat absorption occurs. Except for niacin and vitamin D which are formed from tryptophan and cholesterol, respectively, vitamins cannot be synthesised in human cells. The functions of all vitamins are summarised in Table 3. Deficiencies of vitamins generally result in metabolic disorders and diseases with characteristic syndromes. In this section, we review those vitamins whose deficiencies in pregnancy are most commonly associated with poor maternal and fetal outcomes, namely vitamins A, B6, B12, D, and folate.

Table 3.  Nutritional needs of vitamins for maternal health and fetal growth and development
 Rich dietary sourcesGeneral actionsSpecial importance during pregnancyConsequences of insufficiency in pregnancy
  1. ATP, adenosine triphosphate; FAD, Flavin adenine dinucleotide; FMN, Flavin mononucleotide; IUGR, intra-uterine growth restriction; NAD, Nicotinamide adenine dinucleotide; NADP, Nicotinamide adenine dinucleotide phosphate.

BiotinMeat, fresh vegetablesCoenzyme A for ATP-dependent carboxylasesEmbryonic survival and development; consumption of raw eggs increases risk for biotin deficiencyAnorexia, depression, dermatitis, muscle pain
FolateGreen leafy vegetables, legumes, fortified foods (folic acid)Essential for one-carbon-unit metabolism and DNA synthesis; removal of homocysteineFormation of neural tube; formation of red blood cellsNeural tube defects (spina bifida and anencephaly)
Vitamin A (retinol and carotenoids)Whole milk, liver, eggs, dark coloured fruits and vegetablesComponent of visual pigment in retina; regulates gene expression; plays an important role in development and function of immune system; epithelial cell functionEmbryonic and fetal survival; regulate haematopoiesis; fetal growth and development; potential teratogenicity at high intake of vitamin AMaternal ocular problems (e.g. night blindness); potential detrimental impact on maternal and fetal immune function; higher risk of maternal anaemia
Vitamin B1 (thiamin)Meat, unrefined cerealCoenzyme for decarboxylase complexes in glucose and amino acid degradationProduction of ATP from glucose in the brain; fetal growth and development; maternal healthAnorexia, maternal weight loss, neurological symptoms, muscle degeneration, IUGR
Vitamin B2 (riboflavin)Meat, grains, legumesComponent of FAD and FMN required for oxidoreductases, amino acid oxidases, and other flavoprotein enzymesNutrient metabolism; fetal growth and development; maternal healthMaternal skin lesion, dermatitis, nerve degeneration, IUGR
Vitamin B3 (niacin)Meat, fresh vegetablesComponent of NAD and NADP required for oxidoreductases; post-translational modifications of a variety of proteins via poly(ADP-ribose) polymerasesNutrient metabolism; embryonic and fetal survival; fetal growth and development; maternal healthFour-D syndromes: dermatitis, diarrhoea, dementia, and death; IUGR
Vitamin B5 (pantothenic acid)Meat, whole grain cereals, legumes, fresh vegetablesComponent of coenzyme A for numerous key enzymes (including dehydrogenases); a prosthetic group in acyl carrier protein of the fatty acid synthase complexNutrient metabolism; embryonic and fetal survival; fetal growth and development; maternal healthLoss of appetite, skin lesion, depression, weakness, fatigue, IUGR
Vitamin B6 (pyridoxal phosphate)Meat, dairy products, nuts, fresh vegetablesCoenzyme for amino acid transaminases and decarboxylases, as well as threonine aldolase; covalently bound to muscle glycogen phosphorylaseAmino acid metabolism, removal of ammonia, muscle functionAnaemia, skin lesion, depression, seizure, nausea, vomiting
Vitamin B12 (cobalamin)MeatParticipate in one-carbon-unit metabolism and conversion of homocysteine into methionineNeurological development and function; formation of red blood cellsAnaemia, homocysteinemia, cardiovascular dysfunction, neurological disorders, oxidative stress
Vitamin CFresh vegetables, fruitsHydroxylation of protein-bound proline and lysine; antioxidant; promote iron absorptionConnective tissue growth and development; protect mother and fetus from oxidative stressSubcutaneous haemorrhage; defective collagen structure
Vitamin DCan be synthesised de novo by humans in exposure to sunlight; fatty fish; fortified milkSteroid pro-hormone; influences innate and adaptive immune function; stimulates growth of osteoclasts; allows body to absorb calcium and phosphorusAbsorption of dietary calcium and phosphorus to support fetal growth and development; potential toxicity at high intakeImpaired skeletal growth; IUGR; rickets
Vitamin EVegetable oils; animal fats; meat; fresh vegetablesAntioxidant; stabilise cell membraneEmbryonic and fetal survival life-span of red blood cellsMaternal and fetal anaemia; muscle weakness
Vitamin KVegetables; animal products; intestinal synthesis by bacteriaGeneration of biologically active clotting factorsStop bleeding when a blood vessel is cut.Risk for maternal haemorrhage

Pyridoxal phosphate (the active form of vitamin B6), folic acid (the synthetic form of folate), and vitamin B12 (methylcobalamin) are of considerable importance in fetal development because of their role in one-carbon-unit metabolism (Figure 1). These reactions are critical for the production of DNA bases, the conversion of homocysteine into methionine, neurological and immunological function, growth and development, and the formation of red blood cells.53–55 Additionally, vitamin B6 is required for the synthesis of neurotransmitters, polyamines and histamine, as well as the removal of ammonia from the body.53 Of particular interest, vitamin B6 has been used to treat women for pregnancy-associated nausea and vomiting.56


Figure 1. Metabolism of one-carbon units in mammals. Folate, histidine, methionine, glycine and serine participate in the transfer of one-carbon units for the synthesis of purines and DNA as well as methylation reactions in mammals. The enzymes catalysed the indicated reactions are: (1) folate reductase; (2) N5-N10-methylene H4-folate dehydrogenase (a trifunctional enzyme possessing N10-formyl H4-folate synthetase, N5-N10-methylene H4-folate dehydrogenase, and N5-N10-methenyl H4-folate cyclohydrolase activities); (3) N10-formyl H4-folate dehydrogenase; (4) serine hydroxymethyl transferase; (5) N5-N10-methylene H4-folate reductase; (6) methionine synthase; (7) S-adenosylmethionine synthase; (8) S-adenosylmethionine as a major methyl group donor in methyltransferase-catalyzed reactions; (9) formiminotransferase-cyclodeaminase (a bifunctional enzyme possessing glutamate formiminotransferase and formimidoyl H4-folate cyclodeaminase activities); (10) serine hydroxymethyl transferase, N5-N10-methenyl H4-folate cyclohydrolase, and spontaneous reaction at pH 4–7.0; (11) N5-N10-methenyl H4-folate synthetase; (12) a sequential series of enzymes: histidase, urocanase, and imidazolone propionate hydrolase; (13) thymidylate synthase; and (14) formyltransferase. ATP, adenosine triphosphate; dTMP, deoxythymidine 5′-monophosphate; dUMP, deoxyuridine 5′-monophosphate; Gly, glycine; H4-folate, tetrahydrofolate; NADPH, nicotinamide adenine dinucleotide phosphate; SAM, S-adenosylmethionine; Ser, serine; Vit, vitamin.

Download figure to PowerPoint

Folate has a close metabolic inter-relationship with vitamin B12 (cobalamin).57 Vitamin B12 is required for the conversion of N5-methyl-tetrahydrofolate into tetrahydrofolate, which is the active form of folate involved in the synthesis of DNA, and the metabolism of homocysteine. Folate is essential to embryonic, fetal and infant growth and development58, and deficiency in early pregnancy can disrupt neural tube formation. As well, deficiencies of folate or B12 disrupt red blood cell production resulting in megaloblastic anaemia.54 However, because of the re-absorption of bile-derived vitamin B12 by the small intestine, acute deficiency is not common in women who enter pregnancy with adequate stores.55 Nonetheless, because vitamin B12 is only found in animal source foods, vegans, vegetarians, and those who do not have the resources to obtain animal source foods (i.e. very poor women) are at risk for B12 deficiency.

Vitamin A (retinol) and its metabolites exhibit metabolic and regulatory versatilities in humans. Retinal, an isomer of retinol, is a component of rhodopsin, the visual pigment that is responsible for vision under low-light conditions. Second, retinol and its derivatives (including retinoic acid) bind nuclear proteins to regulate gene expression, cell proliferation, and differentiation in diverse cell types, including immunocytes and epithelial cells.59 Third, vitamin A and its metabolites play an important role in development and function of the immune system by promoting: (1) proliferation and differentiation of lymphocytes; (2) activation of T-cells to synthesise cytokines; (3) tissue-specific lymphocyte homing; (4) production of antigen-specific antibodies; and (5) generation of a large amount of NO (a mediator of the immune response) by activated macrophages.60 Fourth, retinol is necessary for alveolar formation and lung development in early gestation. Fifth, retinoic acid participates in the synthesis of glycoproteins, which accounts for, in part, its effect on enhancing cell growth and differentiation, as well as functional integrity of all epithelial cells. Last, vitamin A regulates haematopoiesis by stimulating the differentiation of stem cells into red blood cells. Thus, a deficiency of vitamin A can cause embryonic death and impair fetal survival, growth and development.61 Night blindness in pregnancy, a consequence of severe vitamin A deficiency, is associated with maternal and neonatal mortality and IUGR. However, it should be noted that high doses of vitamin A, especially in early gestation, are teratogenic.62 Thus, caution should be taken in supplementing pregnant women with high doses of vitamin A. β-Carotene is a good source of vitamin A for humans and is not known to be teratogenic.63

Vitamin D is a steroid prohormone. In humans, when the skin is exposed to sunlight, 7-dehydrocholesterol is converted to cholecalciferol (vitamin D3).64 Vitamin D is metabolised to 1,25-dihydroxyvitamin D3 (calcitriol, a hormone) which plays a central role in calcium and phosphate metabolism and, therefore, bone accretion and mineralisation.64 Specifically, through regulation of gene expression, calcitriol has three effects: (1) activating the vitamin D-dependent calcium and phosphate transport systems in the small intestine; (2) stimulating the growth of osteoclasts; and (3) enhancing calcium resorption by the kidney. Additional regulatory functions for calcitrol in non-skeletal tissues have been identified in recent years. One of the first extra-skeletal tissues identified was the placenta.65,66 Although evidence is limited, it has been hypothesised that the immunosuppressive effects of calcitrol dampen the immune response against the early conceptus to promote successful implantation.67,68

Consequences of maternal malnutrition on maternal and fetal health outcomes

  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

Overall negative impacts

Both undernutrition and overnutrition can be classified as malnutrition because these two extremes of nutrition are commonly characterised by (1) imbalances of nutrients (e.g. amino acids, PUFA, vitamins and minerals); (2) elevated levels of cortisol in blood; and (3) oxidative stress.2,16 Maternal malnutrition during pregnancy can result in a plethora of problems in both mother and fetus (Figure 2). In the following sections, we will focus on the implications of malnutrition in pregnancy for fetal growth and development and maternal health.


Figure 2. Major negative impacts of maternal malnutrition on mother and fetus. Either undernutrition or overnutrition of pregnant women can negatively affect maternal and fetal health, pregnancy outcome, and offspring well-being in the neonatal period, childhood and adulthood. Maternal malnutrition also has long-term adverse effects on the health of both mother and offspring. IUGR, intrauterine growth restriction.

Download figure to PowerPoint

Impact of maternal undernutrition

The prenatal growth trajectory of all species is sensitive to direct and indirect effects of maternal nutrition at all stages between oocyte maturation and birth.64 Epidemiological studies of the Dutch famine (November 1944–May 1945) have shown that maternal undernutrition of women during the second or third trimester, but not the first trimester, reduced birthweight, birth length, and head circumference of infants.69 Because of ethical concerns, animal models have often been used to gain clarification on how the timing of exposure modifies the effects of maternal undernutrition on fetal development.70–81 Results from these studies indicate that deficiencies of energy or macronutrients during the first trimester of pregnancy have a greater detrimental effect on fetal development than during late gestation.82–88 For example, severe global undernutrition during the peri-conceptual period accelerates maturation of the fetal hypothalamic–pituitary–adrenal axis and causes preterm delivery in ewes.71 Also, low pre-pregnancy body weight, followed by global undernutrition during mid pregnancy, reduces placental growth and birthweight in adult sheep.73 Depending on nutritional status before breeding, maternal undernutrition during early and mid-gestation may result in variable effects on the placental and fetal growth trajectory in sheep;75–77 however, all studies have shown that, if undernutrition is prolonged to late pregnancy, fetal growth is greatly reduced, particularly in twin pregnancies.73,78 Regarding specific nutrients, the animal studies suggest that the embryo/fetus is most vulnerable to maternal deficiency of protein or amino acids during the peri-implantation period and the period of rapid placental development.3 Furthermore, the early to mid gestation is the critical period when a deficiency of micronutrients (vitamins and minerals) has greatest adverse impacts on fetal growth and development.79–81 For example, adequate folate during the first trimester is important for the formation, development, and closing of the neural tube in humans.9

Impact of maternal obesity

While the majority of this review focuses on undernutrition, overnutrition in pregnancy has distinct metabolic consequences during pregnancy that increase the risk for poor maternal, fetal and neonatal/infant outcomes.2 Obese women at any period of gestation may experience a metabolic syndrome that is characterised by elevated levels of glucose, hyperinsulinaemia, hyperlipidaemia, hypertension and insulin resistance.16 With regards to timing of overnutrition, evidence shows that maternal obesity before or during pregnancy has negative impacts on fetal growth and development.13 However, the presence of obesity in the first trimester of gestation appears to be most detrimental to embryonic/fetal survival and growth.3 Interestingly, obese mothers who lose weight during part or all of the gestation have increased risk for IUGR. This apparent paradox may be explained by: (1) ketosis resulting from the mobilisation of white fat stores and partial oxidation of fatty acids in the liver; (2) deficiencies of nutrients (e.g. glutamine and micronutrients) in the fetus because of increased utilisation by maternal tissues (e.g. kidneys) and impaired utero-placental blood flow; and (3) elevations of cortisol that inhibit fetal protein synthesis. During the perinatal period, infants of obese women are at increased risk for metabolic distress, stillbirths, neonatal hypoglycaemia, neonatal deaths, congenital abnormalities, and cardiac dysfunction.13

Specific effects of maternal undernutrition on birth outcomes

  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

Effects of maternal undernutrition on the fetal immune system

The immune system protects the host from various pathogens and consists of the innate (natural, non-specific) and the acquired (adaptive, specific) systems.89 The innate immune system provides the early response to invading microbes, but it is non-specific and lacks a memory effect. After a few days, if infection cannot be fully cleared by the innate immunity, the adaptive immune system is activated. At birth, the innate and acquired immune systems are largely present in infants but remain functionally immature.89 As pointed out earlier in this review, the development of both innate and acquired immune systems in the fetus is highly dependent upon an adequate availability of macro and micro nutrients.27,90,91 Epidemiological and experimental data from both human and animal studies suggest that maternal deficiencies of energy, protein, fatty acids and micronutrients during gestation seriously compromises development of the fetal immune system, increase the risk of infectious diseases in infants, and have long-term adverse effects on the adults.1,89,92,93–95

Intrauterine growth restriction

Intrauterine growth restriction is defined as impaired growth and development of the mammalian embryo/fetus or its organs during pregnancy.2 In clinics, IUGR is often diagnosed as birthweight below the 10th percentile of the birth-weight-for-gestational-age reference curve. The risk of IUGR is higher among women with low pre-pregnancy body mass index (BMI), low weight gain during pregnancy, short stature, anaemia, and micronutrient deficiencies (e.g. iron and zinc).7,46,96–100 IUGR infants represent 11% of all newborns in low- and middle-income countries and also a large number of all newborns in high-income nations, e.g. approximately 5% in the US.21 Given the large population of infants in low- and middle-income nations, IUGR induced by maternal undernutrition is a major health problem worldwide.

Maternal undernutrition or overnutrition during gestation reduces fetal growth in both humans and experimental animals.1,3,13,101–105 Animal studies have revealed complex biological mechanisms responsible for IUGR (Figure 3).3 These mechanisms have been corroborated with clinical observations and include: (1) reduced placental growth and vascularity; (2) impaired placental function (including the capacity for transport of basic, neutral, and acidic amino acids as well as glucose); (3) oxidative stress in the placenta and conceptus; (4) reduced concentrations of haemoglobins (because of iron deficiency) for oxygen transport; and (5) impaired cell signalling for regulation of protein synthesis in the placenta and fetus.2,3 A growing body of evidence supports the idea that NO and polyamines, which are products of arginine catabolism, play important roles in placental growth34,106 and, therefore, fetal growth.107–112 During late (week 33) gestation, daily intravenous infusion of L-arginine (20 g/day) for 7 days to women with unknown causes of IUGR increased birthweight at term (week 39) by 6.4%.103 Possibly through increasing NO bioavailability in the vasculature26 and improved placentation,104 multiple micronutrient supplementation (vitamins plus minerals) to low-income pregnant women enhanced fetal growth105,110 and reduced the proportion of low birthweight infants.105 Similar results were obtained with dietary supplementation of folic acid plus iron110 or multiple micronutrients.111 A meta-analysis of studies in low- and middle-income country settings also reported that multiple micronutrient supplementation during pregnancy provided some benefits with regards to fetal growth.9


Figure 3. Biochemical mechanisms responsible for malnutrition-induced intrauterine growth restriction (IUGR) and its transgenerational effects in humans. Maternal undernutrition or overnutrition during pregnancy can result in imbalances of nutrients, oxidative stress, as well as endocrine and metabolic disorders. The negative impacts of these changes include reductions in placental growth (including vascular growth) and utero-placental transfer of nutrients and oxygen from mother to fetus, thereby causing IUGR. Fetal growth retardation increases the risk for birth defects and other adverse pregnancy outcomes. Results of recent studies indicate that the effects of IUGR may be passed onto next generations via epigenetics in a sex-dependent manner (fetal programming).

Download figure to PowerPoint

There are concerns that pregnancy may negatively impact maternal nutritional status because of an increase in utero-placental blood flow, nutrient mobilisation, and transfer of nutrients from mother to fetus. Findings from well-controlled animal studies indicate that, in mothers who were adequately nourished before conception and then underfed during pregnancy, maternal nutritional status was well preserved.107–110,112 This preservation may result from increased efficiency of metabolic transformations.107–109 It should be noted that limited evidence exists in humans to support or refute the preservation of maternal nutritional status during pregnancy. As well, in resource-poor settings, women commonly enter pregnancy undernourished. Their nutrition and health status may be further compromised by other factors such as short interpregnancy intervals, early age at first pregnancy, and infection. Together, these factors may exacerbate the potential detrimental effects of undernutrition during pregnancy on maternal nutritional status.

Preterm birth

Preterm birth (<37 weeks) is a leading cause of infant morbidity and mortality worldwide, and occurs in approximately 10% of pregnancies globally.113 The incidence of preterm birth is particularly high in certain countries (e.g. approximately 23% in rural Nepal, 21% in India, and 17% in Bangladesh). Significant disparities also exist in prevalence even in the same nation (e.g. 17–19% for African Americans vs. 7–8% for whites). Immature infants have numerous complications, including respiratory distress syndrome, intraventricular haemorrhage, necrotising enterocolitis, sepsis, hyperammonaemia, and increased risk of mortality. Preterm labour results from premature and sustained activation of the uterine myometrium or placental dysfunction and abruption.114,115 Placental abruption is a condition in which the placenta detaches prematurely from the uterine wall. Four factors can stimulate the contraction of the uterine myometrium: (1) mechanical stretch of the uterus; (2) enhanced production of prostaglandin F (PGF) by uterus, placenta and fetus; (3) elevated levels of hormones (e.g. cortisol and oxytocin); and (4) reduced bioavailability of NO.115–120 In response to malnutrition as a stress factor, high levels of cortisol and oxytocin are produced by the mother and the fetus. These hormones trigger a pro-inflammatory response that increases intracellular calcium, which triggers a cell signalling cascade resulting in uterine contraction (Figure 4).119–122 Thus, malnutrition plays a key role in activating a series of physiological responses, leading to preterm birth (Figure 4). Improvement of maternal nutrition during gestation potentially decreases the risk for preterm birth by two mechanisms: (1) reducing the circulating levels of cortisol and oxytoxin; and (2) increasing NO bioavailability through up-regulation of NO synthesis from arginine and inhibition of NO oxidation by antioxidative micronutrients.


Figure 4. Biochemical mechanisms responsible for malnutrition-induced preterm birth and its amelioration by dietary supplementation in humans. Maternal undernutrition or overnutrition represents a stress factor that can stimulate the release of cortisol and oxytoxin from the adrenal gland and the posterior pituitary gland, respectively. These hormones enhance the production of prostaglandin F (PGF) by the fetus, placenta and uterus. Oxytoxin and (PGF) bind their respective G-protein-coupled receptors, leading to an increase in intracellular concentrations of Ca2+ via the phospholipase C and inositol 1,4,5-trisphosphate pathway. High levels of Ca2+ activate the preterm contraction of the uterus, thereby stimulating preterm birth. In contrast, physiological levels of nitric oxide (NO), which is synthesised from L-arginine by endothelial NO synthase (eNOS), inhibit the preterm contraction of the uterus. The generation of NO in the vasculature is up-regulated by ω3 polyunsaturated fatty acids (PUFA). Dietary supplementation with antioxidant micronutrients, ω3 PUFA, and arginine can be beneficial in reducing the risk of preterm delivery in pregnant women. The signs (+) and (−) denote activation and inhibition, respectively.

Download figure to PowerPoint

While there have been inconsistent reports in the literature regarding effects of maternal nutrition on gestational length in humans, both maternal undernutrition and overnutrition are associated with reduced gestational length in well-controlled experimental animals.3 For example, in adult sheep, severe global undernutrition during the peri-conceptual period causes preterm delivery in association of activation of the hypothalamic–pituitary–adrenal axis for cortisol synthesis.121 Likewise, in rhesus monkeys, high protein intake (4 vs. 1 g/kg body weight per day) substantially reduced gestational length by up to 2 weeks likely because of endocrine imbalance and adverse effects of metabolites (e.g. ammonia and H2S) of amino acid oxidation.123 Human clinical studies also indicated that increased intake of dietary sugar was associated with reduced gestational length in pregnant adolescents.124 In contrast, higher maternal BMI either in the first trimester or throughout gestation was associated with longer gestation in obese women in developed nations,13 possibly because of impaired contraction of the uterus. In contrast, excessive gestational weight gain, but not pre-pregnancy BMI, was positively associated with spontaneous preterm delivery.125 The major component of the excessive maternal weight gain in these women is likely white adipose tissue, which can be associated with oxidative stress. In support of this view, a deficiency of micronutrients in the periconceptional period or throughout gestation is associated with high incidence of preterm births.104 Similarly, in a separate study, severely obese women who lost weight during pregnancy generally had increased risk for preterm birth,126 possibly as a result of malnutrition, ketosis, and other metabolic disorders.

Low-income women frequently have inadequate intake of multiple micronutrients127 and many in developing countries may have short stature because of chronic malnutrition beginning in early childhood.7 Maternal short stature has been correlated with reduced gestation length.125 In micronutrient-deficient women, evidence from some clinical studies suggests an important role for dietary supplementation with micronutrients in reducing the risk of preterm births. For example, a meta-analysis of zinc supplementation in pregnancy showed a 14% reduction in the risk of preterm delivery among supplemented women.10,127,128 In another meta-analysis, calcium supplementation during pregnancy was associated with a 24% reduction in the risk of preterm delivery.41 Also, one study involving a prospective cohort of pregnant women (aged ≥16 years) with singleton gestations reported that women with low intake of dietary vitamin C (<10th percentile) had twice the risk of preterm birth because of premature rupture of the membranes.129 Thus, improving the nutritional status of vitamin C is beneficial for maintaining normal gestational length. Consistent with this conclusion, results from one trial indicate that daily supplementation with 100 mg vitamin C, which was initiated after 20 weeks of gestation, reduced the incidence of premature rupture of the chorioamniotic membranes in pregnant women by 69%.130

Birth defects

Neural tube defects are one of the most severe developmental disorders of the fetal brain and spinal cord.131 These organs arise from specialised cells of the embryo early in pregnancy (18–28 days).131 The timing of their development epitomises the importance of adequate maternal nutrition before gestation and in the first trimester. The two most common neural tube defects are spina bifida and anencephaly.132 These birth defects occur commonly worldwide (e.g. approximately one in 1000 births in the US).132 Compelling evidence suggests that a deficiency of folate or an excess of homocysteine (a metabolite of methionine) during pregnancy contributes to neural tube defects in newborn infants.58 Additionally, through similar mechanisms as neural tube defects, folate deficiency is also associated with increased risk of both cleft lip and palate.133 As noted previously, folate is required for DNA synthesis in all cell types, particularly the central nervous system which develops rapidly during early and mid gestation. Moreover, homocysteine is an oxidant that damages macromolecules, including DNA, proteins and lipids.31 In humans who have adequate intake of water-soluble vitamins, homocysteine is effectively recycled into methionine through a folate- and vitamin B12-dependent reaction (methionine synthase) (Figure 1). Results of clinical studies indicate that dietary supplementation with folic acid (e.g. 4 mg per day for pregnant women) can effectively prevent neural tube defects caused by malnutrition.134 In several countries (e.g. US, Canada, Chile, and South Africa), significant reductions in the incidence of neural tube defects followed the large-scale efforts to fortify flours with folic acid.134,135 Adequate provision of B-complex vitamins (particularly folate and vitamin B12) and the balance of dietary amino acids (especially sulfur amino acids, glycine, serine, histidine and arginine) are critical for the prevention of these birth defects.

Iodine deficiency disorders

Iodine deficiency is a major nutritional problem around the world, particularly in pregnant women.136,137 As noted previously, iodine is required for synthesis of thyroid hormones. When circulating levels of thyroxine are reduced, the pituitary gland increases the secretion of thyroid stimulating hormone (TSH) to enhance iodine trapping by the thyroid gland as an adaptive response. Persistent elevation of TSH in response to chronic severe iodine deficiency results in the enlargement of the thyroid gland, and ultimately goiter. Severe iodine deficiency in pregnant women causes fetal iodine deficiency and congenital hypothyroidism which may lead to mental and physical-growth retardation of the offspring, known as cretinism.46 Less severe iodine deficiency during pregnancy impairs fetal neurological development and the cognition of offspring.138 Accordingly, supplementing women with iodine before and during gestation can prevent both goiter and cretinism.139 Prevention of iodine deficiency in iodine-deficient regions can be effectively achieved through the use of iodised salt42 although iodine intakes through fortified salt may not meet the increased needs of pregnant women.

Effects of malnutrition in pregnancy on maternal health and survival

Rates of maternal morbidity and mortality remain unacceptably high in many parts of the world. Haemorrhage is the leading cause of maternal death globally, followed by hypertensive disorders of pregnancy such as pre-eclampsia and eclampsia.5 Anaemia and obstructed labour are also substantial contributors to maternal mortality, especially in Southeast Asia and Latin America, respectively.140 Numerous studies report a role for maternal nutrition in these poor health outcomes.1,132,141 Here we discuss the mechanisms by which malnutrition may contribute to adverse maternal health.

Hypertensive disorders of pregnancy

Pre-eclampsia is a significant obstetrical complication that affects 5–7% of pregnancies globally. This complication is generally diagnosed after 20 weeks of gestation and is characterised by increased blood pressure and traces of protein in maternal urine (a condition called ‘proteinuria’).142 In low-income countries, the incidence of pre-eclampsia is up to 10% of all pregnancies and 2.3% of pre-eclamptic women further develop eclampsia. Pre-eclampsia is a leading cause of IUGR, maternal death, and infant morbidity and mortality associated with preterm birth. Although the underlying mechanisms remain elusive, recent studies have provided clinical and biochemical evidence for oxidative stress, reduced bioavailability of NO in the vasculature, and endothelial cell dysfunction in pre-eclamptic women.143–145

While pre-eclampsia may have a genetic basis, poor nutrition may play a key role in its pathogenesis. Given the potential aetiologies for pre-eclampsia, numerous studies have tested the effects of supplementation with antioxidants (e.g. arginine, vitamins C and E, zinc, selenium and glutathione), calcium, or vitamin D to prevent pre-eclampsia.37,51,146–152 Salt restriction diets among at risk women151 and arginine supplementation of pre-eclamptic women have also been tested for prevention and/or treatment of pre-eclampsia.146 A recent WHO technical consultation systematically reviewed and evaluated the evidence base for some of these interventions to prevent and/or treat hypertensive disorders of pregnancy. Of the nutritional interventions included, calcium supplementation among women with low calcium intake was strongly recommended to prevent pre-eclampsia while magnesium sulfate was recommended to treat pre-eclampsia and prevent progression to eclampsia.152 The Technical Consultation did not find sufficient evidence to support recommending supplementation with vitamins C, E or D or dietary salt restriction in the prevention of pre-eclampsia. However, arginine was not included in this consultation.152 It is noteworthy that plasma levels of arginine were reduced in pre-eclamptic compared with healthy pregnant women,144 thereby impairing NO generation by endothelial cells.26 Thus, a study involving women with pre-eclampsia reported that oral administration of arginine (3 g daily for 4 weeks) beginning at 29 weeks of gestation reduced blood pressure, prolonged pregnancy, improved fetal well-being, and enhanced fetal growth.145 Similar results were reported for pregnant women with high-risk pre-eclampsia.146

Calcium deficiency during pregnancy is associated with increased risk of hypertensive disorders. A recent systematic review and meta-analysis indicated that calcium supplementation is associated with a 50% reduction in the risk of gestational hypertension, pre-eclampsia and preterm delivery.39 Similarly, daily supplementation with 1.5 g of calcium reduced the severity of pre-eclampsia and early preterm labour in nulliparous normotensive women who had low dietary intake of calcium (<600 mg/day).37 These beneficial outcomes of calcium supplementation may be because of up-regulation of NO synthesis from arginine by endothelial cells, thereby enhancing the bioavailability of this vasodilator in the vasculature.40

Maternal haemorrhage

Maternal haemorrhage refers to the substantial loss of the mother's blood at delivery and accounts for approximately 60% of all maternal deaths in developing countries.141 When the placenta is separated from the wall of the uterus, the maternal blood vessels that previously supplied blood to the placenta are sheared, resulting in bleeding. Such bleeding is normally stopped by the spontaneous contraction of the uterus and the compression of its vessels. However, when uterine contraction is inadequate, bleeding will continue and haemorrhage can occur. In developing nutritional means to prevent maternal haemorrhage, it should be recognised that blood clotting is affected by the amounts of coagulation factors (proteins that are synthesised from amino acids) and their Ca2+- and vitamin K-dependent activities.44 Thus, theoretically, in addition to energy (ATP provision), nutrients that can beneficially improve uterine contraction without inducing premature labour include amino acids (notably arginine and glutamine), minerals (particularly calcium and iron), long-chain PUFA (e.g. arachidonic acid and ω3-PUFA), and vitamins (especially vitamin K and A).140 In support of this view, there is evidence that undernutrition and overnutrition are associated with increased risk for maternal haemorrhage.136,141 This condition can result in iron deficiency, anaemia, morbidity and maternal death.

Maternal anaemia

Based on the chemical composition of haemoglobin, a deficiency of amino acids or iron in the maternal diet can cause anaemia.31,46 A deficiency of vitamins (vitamin B6, vitamin B12 and folate) and minerals (cobalt, magnesium, zinc and copper) that participate in one-carbon-unit metabolism and, therefore, DNA synthesis can also indirectly result in anaemia.153–155 Furthermore, insufficient provision of dietary nutrients (e.g. vitamin A, lipids and carbohydrates) that are essential to the integrity of intestinal epithelial cells, the function of enterocytes, and the absorption of vitamins and minerals can also increase the risk for the development of anaemia.156 Thus, a balanced and adequate supply of all nutrients is crucial to prevent anaemia in humans. However, the causes of anaemia are not solely nutritional. Malaria, parasitic infections, and inherited thallasemias and haemoglobinopathies can also result in anaemia independent of nutrition and the relative contributions of each of these factors to the burden of anaemia is highly context-specific.140 Fully integrated approaches that address the nutritional, infectious and genetic aetiologies of anaemia are needed to develop effective interventions.

Pregnant women with anaemia have a reduced capability for: (1) oxygen transport from the heart to central and peripheral tissues; and (2) impaired metabolism of macronutrients and ATP production. Thus, these subjects often exhibit pale skin, weakness and fatigue. In its severe and acute form (<70 g haemoglobin/L), anaemia can lead to rapid cardiac decompensation and cardiac failure. Indeed, it is estimated that 6.4%, 7.3% and 3.0% of maternal mortality is attributable to severe anaemia in Africa, Asia and Latin America, respectively.140 When severe anaemia is not a primary cause of death, it may be a contributing indirect factor, for example, by increasing the inability of a woman to tolerate blood loss from haemorrhage or by increasing her risk of infection.156 The contribution of less severe anaemia to the burden of maternal mortality is less well documented, though recently, Stoltzfus et al.6 estimated that a population increase in maternal haemoglobin by 1 g/dL could reduce the risk of maternal mortality by approximately 25%. With regards to anaemia as an indirect contributor to mortality through increased risk of haemorrhage, the epidemiological evidence suffers from substantial methodological shortcomings and is largely inconsistent.4,140 However, a recent clinical study in Zanzibar reported that among women presenting at a clinic with uncomplicated vaginal deliveries, those with moderate or severe anaemia lost significantly more blood during and immediately after delivery compared with nonanaemic women.157 The researchers hypothesised that women with moderate to severe anaemia may have decreased uterine blood flow or low uterine muscle strength which contributed to inefficient uterine contractions and greater blood loss.157

Implications of IUGR and other poor pregnancy outcomes for human health

  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

Impact of IUGR on infants and children

Intrauterine growth restriction is a significant factor contributing to fetal deaths and preterm births.158,159 For example, IUGR is responsible for about 50% of non-malformed stillbirths in humans. Furthermore, Heinonen et al.158 reported that different types of IUGR contribute to approximately 40% of preterm births. IUGR infants delivered at preterm gestations have severe perinatal and neonatal medical complications. Of note, the rates of neonatal morbidity and mortality among preterm IUGR infants are much higher than those among appropriately grown preterm infants with similar gestational age.158 Thus, infants who weigh <2500 g at birth have perinatal mortality rates that are five- to 30-fold greater than those of infants who have average birthweights, while infants that weigh <1500 g have 70- to 100-times greater mortality rates.159 Compelling evidence shows that surviving infants with IUGR are often at increased risk for neurological, respiratory, intestinal, immunological and circulatory disorders during the neonatal period and childhood.159 For girls who suffer from IUGR, short stature can lead to obstructed labour in the future.156

Impact of IUGR on chronic diseases

The adaptation of the IUGR fetus or offspring to in utero or extrauterine environments may confer an evolutionary advantage for the survival of the species. However, when environmental cues during prenatal life inappropriately programme offspring, there are adverse consequences, including the increased prevalence of disease in adult life which may result, in part, from a reduced availability of nutrients to the fetus in utero.2 Both epidemiological and experimental evidence indicate that IUGR contributes to a plethora of metabolic disorders and chronic diseases in adults.1,160,161 These problems include: (1) hormonal imbalance (e.g. increased plasma levels of glucocorticoids and renin; decreased plasma levels of insulin, growth hormone, and insulin-like growth factor-I); (2) metabolic disorders (e.g. insulin resistance, β-cell dysfunction, dyslipidemia, glucose intolerance, impaired energy homeostasis, obesity, type-II diabetes, oxidative stress, mitochondrial dysfunction, and ageing); (3) organ dysfunction and abnormal development (e.g. testes, ovaries, brain, heart, skeletal muscle, liver, thymus, and small intestine); and (4) cardiovascular disorders (e.g. coronary heart disease, hypertension, stroke, and atherosclerosis).2,3 Hence, infants who survive the adverse consequences of IUGR through the neonatal period may face an increased risk of poor health in adulthood.

Fetal programming

The fetus may survive extreme conditions in utero through physiological adaptations that include changes in gene expression. Epidemiological studies show that individuals exposed to the Dutch winter famine of 1944–1945 in utero had higher rates of insulin resistance, vascular disease, morbidity and mortality in adulthood.162 The intrauterine environment of the conceptus may alter expression of the fetal genome and have lifelong consequences. This phenomenon is termed ‘fetal programming’, which has led to the theory of fetal origins of adult disease.163 Namely, alterations in fetal nutrition and endocrine status may result in developmental adaptations that permanently change the structure, physiology and metabolism of the offspring, thereby predisposing individuals to metabolic, endocrine and cardiovascular diseases in the adult lives of both animals and humans.

Fetal programming may be explained by epigenetics, which is defined as stable and inheritable alterations of genes through covalent modifications of DNA and core histones without changes in DNA sequences.164 The concept of fetal programming has now been experimentally tested in a number of animal models, including rats, mice, cattle and sheep,16 and has shown that the effects of changes in nutrition or endocrine status during fetal or neonatal life can be carried forward to subsequent developmental stages.165 Because DNA methylation, a mechanism mediating epigenetic effects, is reversible, it is likely that metabolic abnormalities in the offspring can be ameliorated through nutritional interventions.164 For example, transgenerational exposure of the agouti mice to an ad libitum diet causes obesity-associated metabolic syndrome in offspring, which can be prevented by dietary supplementation with folate.166 While research is still limited, nutrition is expected to play a key role in developmental plasticity, potential, and programming.

Conclusions and perspectives

  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References

A summary of current knowledge of the field

Development of the human conceptus absolutely depends on adequate and balanced supplies of both macronutrients and micronutrients. During implantation, the embryo receives nutrients from maternal uterine secretions, which include water, protein, amino acids, lipids, and glucose, minerals, and vitamins. After placentation, the fetus takes up nutrients and oxygen from the mother via the umbilical vein. Maternal undernutrition or overnutrition during pregnancy can result in IUGR, which, in turn, is a major factor contributing to reduced neonatal survival, as well as the impairment of postnatal growth, neurological function, learning abilities, and health. Folate deficiency greatly increases the risk of neural tube defects and orofacial clefts in newborns. In addition, severe iodine deficiency results in cretinism which is characterised by impaired neurological development and permanent growth stunting in offspring.

In addition to IUGR, maternal deficiencies of certain nutrients are known to negatively impact the health of mothers. Of particular interest, reduced concentrations of arginine and calcium in the plasma of pregnant women contribute to the pathogenesis of pre-eclampsia and preterm labour. A deficiency of zinc also increases the risk for maternal oxidative stress and premature labour. Furthermore, dietary deficiencies of protein or iron can result in maternal anaemia and may subsequently increase the risk for maternal haemorrhage. Fortunately, strategies to increase intakes of these deficient nutrients, including dietary supplementation, food fortification, dietary diversification, and nutrition education, can potentially alleviate the burden of, and may even completely prevent, certain poor health outcomes.

The prenatal growth trajectory of humans is sensitive to direct and indirect effects of nutritional insults at all stages between oocyte maturation and birth. However, available evidence shows that placental and fetal development is most vulnerable to prenatal nutrition status during the peri-implantation period and the period of rapid placental development (the first trimester of gestation). Specifically, a deficiency of protein and micronutrients during the first trimester of pregnancy has a greater detrimental effect on fetal development than during late gestation. In contrast, energy restriction during mid and late gestation appears to cause a more profound adverse impact on the vasculature than during early gestation. Besides whole-body growth, maternal nutrition influences development of the fetal immune system and, thus, health in postnatal life. Adverse effects of IUGR and other poor pregnancy outcomes can be carried forward to future generations.

Given the significant problems of IUGR and deficiencies of specific nutrients on neonatal and adult life, which include high rates of infant morbidity and mortality as well as adult-onset diabetes and hypertension, much attention has been directed to elucidating the biological mechanisms for IUGR, pre-eclampsia, and birth defects. Compelling evidence indicates that all types of IUGR are characterised by impaired transfer of nutrients from mother to fetus because of placental underdevelopment/dysfunction and reduced utero-placental blood flow. Optimising maternal nutrition will not only reduce risk of maternal/fetal morbidity and mortality, IUGR, and preterm birth, but will also prevent adverse health problems in children and adults. Because the largest detriments appear to occur in early pregnancy when a woman might not be aware that she is pregnant, correcting malnutrition before a woman conceives is likely to yield the greatest benefits for her and her infant.

Directions for future research and perspectives

Much is now known about adverse effects of IUGR and preterm birth on neonatal survival and adult-onset metabolic diseases. Effective nutrition strategies that ameliorate or prevent these problems exist but are complex and require changes in both individual/household behaviour and structural changes that increase women's access to and acceptability of nutritious food, nutrition supplements, and preventive health services. While effective postnatal therapies are required for surviving individuals with IUGR, its prevention should be the best strategy to improve the health and well-being of infants and adults. One effective means is to ensure balanced provision of protein and energy in the diet, which can reduce the risk of IUGR by 32%.8 Similarly, although medications are needed to treat preterm labour, its risk may be substantially reduced by improving maternal nutrition (particularly arginine145,146 and micronutrients10,127,128,130). Despite the previous research efforts focusing on mainly individual nutrients or a mix of multiple micronutrients, there is a paucity of information about interactions among nutrients (e.g. between amino acids and vitamins/minerals or synergism) and their impact on pregnancy outcomes. In view of the exciting findings from animal studies,166–171 it is unfortunate that there has been only limited attention to the use of amino acids to improve pregnancy outcomes in women carrying IUGR fetuses.146,150,172 Additionally, little is known about effects of specific nutrients (particularly amino acids, vitamins and minerals) on epigenetics or fetal programming in mammals.

Future studies with animal models and women are necessary to develop effective means of nutritional interventions to enhance fetal growth and development in undernourished, overweight or obese mothers. Such approaches may include dietary supplementation with nutrients that play a key role in regulating utero-placental blow flow and uterine quiescence during pregnancy. Because amino acids affect not only protein synthesis and tissue growth but also serve as major donors of methyl groups to affect DNA and histone modifications, designing an ideal mixture of functional amino acids and micronutrients for gestating mothers to regulate key metabolic pathways for nutrient metabolism will be highly desirable in the field of prenatal and neonatal research. Finally, we propose that multidisciplinary efforts are required to develop effective solutions to preventing and treating IUGR (a complex nutritional and reproductive health problem), preterm birth, birth defects, and other poor pregnancy outcomes in humans.


  1. Top of page
  2. Abstract
  3. Nutritional needs for fetal growth and development
  4. Consequences of maternal malnutrition on maternal and fetal health outcomes
  5. Specific effects of maternal undernutrition on birth outcomes
  6. Implications of IUGR and other poor pregnancy outcomes for human health
  7. Conclusions and perspectives
  8. Acknowledgements
  9. Conflicts of interest
  10. References
  • 1
    Abu-Saad K, Fraser D. Maternal nutrition and birth outcomes. Epidemiological Review 2010; 32:525.
  • 2
    Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. Journal of Nutrition 2004; 134:21692172.
  • 3
    Wu G, Bazer FW, Wallace JM, Spencer TE. Board-invited review: intrauterine growth retardation: implications for the animal sciences. Journal of Animal Science 2006; 84:23162337.
  • 4
    Rush D. Nutritional and maternal mortality in the developing world. American Journal of Clinical Nutrition 2000; 72:212S240S.
  • 5
    Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:10661074.
  • 6
    Stoltzfus RJ, Mullany L, Black RE. Iron deficiency anaemic. In: Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, Vol. 1. Editors: Ezzati M, Lopez AD, Rodgers A, Murray CJL. Geneva: WHO, 2005; pp. 163209.
  • 7
    United Nations Food and Agriculture Organization. The State of Food Insecurity in the World 2011. 2011.[Accessed on November 12, 2011].
  • 8
    Imdad A, Bhutta ZA. Maternal nutrition and birth outcomes: effect of balanced protein energy supplementation. Paediatric and Perinatal Epidemiology 2012; 26 (Suppl. 1):178190.
  • 9
    Imdad A, Bhutta ZA. Routine iron/folate supplementation during pregnancy: effect on maternal anemia and birth outcomes. Paediatric and Perinatal Epidemiology 2012; 26 (Suppl. 1):168177.
  • 10
    King JC, Chaffee BW. Effect of zinc supplementation on pregnancy and infant outcomes. Paediatric and Perinatal Epidemiology 2012; 26 (Suppl. 1):118137.
  • 11
    Zhu BP, Rolfs RT, Nangle BE, Horan JM. Effect of the interval between pregnancies on perinatal outcomes. New England Journal of Medicine 1999; 340:589594.
  • 12
    Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. Journal of American Medical Association 2006; 295:18091823.
  • 13
    McKnight JR, Satterfield MC, Li XL, Gao HJ, Wang JJ, Li DF, et al. Obesity in pregnancy: problems and potential solutions. Frontiers in Bioscience 2011; E3:442452.
  • 14
    Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstetrics & Gynecology 2011; 118:305312.
  • 15
    Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annual Review of Nutrition 2010; 30:315339.
  • 16
    Satterfield MC, McKnight JR, Li XL, Wu G. Nutrition, epigenetics, and vascular function. In: Nutrition, Epigenetic Mechanisms, and Human Disease. Editors: Maulik N, Maulik G. New York: CRC Press, 2011; pp. 125139.
  • 17
    Fainberg HP, Budge H, Symonds ME. The conflicting effects of maternal nutrient restriction and early-life obesity on renal health. Proceedings of Nutrition Society 2011; 70:268275.
  • 18
    Bazer FW, Wu G, Spencer TE, Johnson GA, Burghardt RC, Bayless K. Novel pathways for implantation and establishment and maintenance of pregnancy in mammals. Molecular Human Reproduction 2010; 16:135152.
  • 19
    Kim JY, Burghardt RC, Wu G, Johnson GA, Spencer TE, Bazer FW. Select nutrients in the ovine uterine lumen: VII. Effects of arginine, leucine, glutamine, and glucose on trophectodem cell signaling, proliferation, and migration. Biology of Reproduction 2011; 84:6269.
  • 20
    Kim JY, Burghardt RC, Wu G, Johnson GA, Spencer TE, Bazer FW. Select nutrients in the ovine uterine lumen: VIII. Arginine stimulates proliferation of ovine trophectoderm cells through mTOR-RPS6K-RPS6 signaling cascade and synthesis of nitric oxide and polyamines. Biology of Reproduction 2011; 84:7078.
  • 21
    Wu G, Bazer FW, Datta S, Johnson GA, Li P, Satterfield MC, et al. Proline metabolism in the conceptus: implications for fetal growth and development. Amino Acids 2008; 35:691702.
  • 22
    Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. Journal of Nutritional Biochemistry 2006; 17:571588.
  • 23
    Kalhan SC, D'Angelo LJ, Savin SM, Adam PAJ. Glucose production in pregnant women at term gestation: sources of glucose for human fetus. Journal of Clinical Investigation 1979; 63:388394.
  • 24
    Haggarty P. Fatty acid supply to the human fetus. Annual Review of Nutrition 2010; 30:237255.
  • 25
    Li P, Kim SW, Li XL, Datta S, Pond WG, Wu G. Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide 2008; 19:259265.
  • 26
    Wu G, Meininger CJ. Regulation of nitric oxide synthesis by dietary factors. Annual Review of Nutrition 2002; 22:6186.
  • 27
    Enke U, Seyfarth L, Schleussner E, Markert UR. Impact of PUFA on early immune and fetal development. British Journal of Nutrition 2008; 100:11581168.
  • 28
    Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. American Journal of Clinical Nutrition 2009; 89:678S684S.
  • 29
    Stein AD, Wang M, Martorell R, Neufeld LM, Flores-Ayala R, Rivera JA, et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition 2010; 141:23162320.
  • 30
    Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera R, Romieu I, Ramakrishnan U. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics 2011; 128:e1e8.
  • 31
    Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 2009; 37:117.
  • 32
    Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, Knabe DA, et al. Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids 2011; 40:10531063.
  • 33
    Wu G. Functional amino acids in growth, reproduction and health. Advances in Nutrition 2010; 1:3137.
  • 34
    Wu G, Bazer FW, Davis TA, Kim SW, Li P, Rhoads JM, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 37:153168.
  • 35
    Wu G, Bazer FW, Johnson GA, Knabe DA, Burghardt RC, Spencer TE, et al. Important roles for L-glutamine in swine nutrition and production. Journal of Animal Science 2011; 89:20172030.
  • 36
    Li XL, Rezaei R, Li P, Wu G. Composition of amino acids in feed ingredients for animal diets. Amino Acids 2011; 40:11591168.
  • 37
    Villar J, Abdel-Aleem H, Merialdi M, Giordano D, Ba'aqeel H, Farnot U, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology 2006; 194:639649.
  • 38
    Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2010; (8):CD001059.
  • 39
    Trumbo PR, Ellwood KC. Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the U.S. Food and Drug Administration. Nutrition Review 2007; 65:7887.
  • 40
    Lopez-Jaramillo P. Prevention of preeclampsia with calcium supplementation and its relation with the L-arginine:nitric oxide pathway. Brazilian Journal of Medicine and Biological Research 1996; 29:731741.
  • 41
    Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatric and Perinatal Epidemiology 2012; 26 (Suppl. 1):138152.
  • 42
    Vanderpas J. Nutritional epidemiology and thyroid hormone metabolism. Annual Review of Nutrition 2006; 26:293322.
  • 43
    Zimmermann MB. The effects of iodine deficiency in pregnancy and infancy. Paediatric and Perinatal Epidemiology 2012; 26 (Suppl. 1):108117.
  • 44
    Institute of Medicine. Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals. Washington, DC: Food and Nutrition Board, Institute of Medicine, National Academies, 2004.
  • 45
    Winzerling JJ, Law JH. Comparative nutrition of iron and copper. Annual Review of Nutrition 1997; 17:501526.
  • 46
    Zimmermann MB. The influence of iron status on iodine utilization and thyroid function. Annual Review of Nutrition 2006; 26:367389.
  • 47
    Stolzfus RJ. Iron interventions for women and children in low-income countries. Journal of Nutrition 2011; 141:756S762S.
  • 48
    Romani AM. Cellular magnesium homeostasis. Archives of Biochemistry and Biophysics 2011; 512:123.
  • 49
    Mercer BM, Merlino AA, Society for Maternal-Fetal Medicine. Magnesium sulfate for preterm labor and preterm birth. Obstetrics & Gynecology 2009; 114:650668.
  • 50
    Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Science 2008; 99:15151522.
  • 51
    Yin JD, Li XL, Li DF, Yue T, Fang Q, Ni JJ, et al. Dietary supplementation with zinc oxide stimulates ghrelin secretion from the stomach of young pigs. J Nutr Biochem 2009; 20:783790.
  • 52
    Merialdi M, Caulfield L, Zavaleta N, Figueroa A, Costigan K, Dominici F, et al. Randomized controlled trial of zinc supplementation and fetal bone growth. American Journal of Clinical Nutrition 2004; 79:826830.
  • 53
    Merrill AH Jr, Henderson JM. Diseases associated with defects in vitamin B6 metabolism or utilization. Annual Review of Nutrition 1987; 7:137156.
  • 54
    Koury MJ, Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annual Review of Nutrition 2004; 24:105131.
  • 55
    Allen LH. Vitamin B12 metabolism and status during pregnancy, lactation and infancy. Advances in Experimental Medicine and Biology 1994; 352:173186.
  • 56
    Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. New England Journal of Medicine 2010; 363:15441550.
  • 57
    Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annual Review of Nutrition 1985; 5:115141.
  • 58
    De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews 2010; (10):CD007950.
  • 59
    Ross AC, Cifelli CJ, Zolfaghari R, Li NQ. Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism. Physiological Genomics 2011; 43:5767.
  • 60
    Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Review in Immunology 2008; 8:685698.
  • 61
    Clagett-Dame M, DeLuca HF. The role of vitamin A in mammalian reproduction and embryonic development. Annual Review of Nutrition 2002; 22:347381.
  • 62
    Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. New England Journal of Medicine 1995; 333:13691373.
  • 63
    Strobel M, Tinz J, Biesalski HK. The importance of beta-carotene as a source of vitamin A with special regard to pregnant and breastfeeding women. European Journal of Nutrition 2007; 46 (Suppl 1):1120.
  • 64
    DeLuca HF. Overview of general physiologic features and functions of vitamin D. American Journal of Clinical Nutrition 2004; 80:1689S1696S.
  • 65
    Christakos S, DeLuca HF. Vitamin D: is there a role in extraskeletal health? Endocrinology 2011; 152:29302936.
  • 66
    Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, et al. The ontogeny of 25-hydroxyvitamin D(3) 1α-hydroxylase expression in human placenta and decidua. American Journal of Pathology 2002; 161:105114.
  • 67
    Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biology of Reproduction 2006; 75:816822.
  • 68
    Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, Equils O, et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biology of Reproduction 2009; 80:398406.
  • 69
    Stein AD, Zybert PA, van de Bor M, Lumey LH. Intrauterine famine exposure and body proportions at birth: the Dutch Hunger Winter. International Journal of Epidemiology 2004; 33:831836.
  • 70
    Pond WG, Strachan DN, Sinha YN, Walker EF Jr, Dunn JA, Barnes RH. Effect of protein deprivation of swine during all or part of gestation on birth weight, postnatal growth rate and nucleic acid content of brain and muscle of progeny. Journal of Nutrition 1969; 99:6167.
  • 71
    Fowden AL, Ralph MM, Silver M. Nutritional regulation of uteroplacental prostaglandin production and metabolism in pregnant ewes and mares during late gestation. Experimental and Clinical Endocrinology 1994; 102:212221.
  • 72
    Fall CHD, Yajnik CS, Rao S, Davie AA, Brown N, Farrant HJW. Micronutrients and fetal growth. Journal of Nutrition 2003; 133:1747S1756S.
  • 73
    Redmer DA, Wallace JM, Reynolds LP. Effect of nutrient intake during pregnancy on fetal and placental growth and vascular development. Domestic Animal Endocrinology 2004; 27:199217.
  • 74
    Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CLS, et al. Low plasma vitamin B-12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia 2009; 52:23502358.
  • 75
    Mellor DJ. Nutritional and placental determinants of fetal growth rate in sheep and consequences for the newborn lamb. British Veterinary Journal 1983; 139:307324.
  • 76
    Kwon H, Ford SP, Bazer FW, Spencer TE, Nathanielsz PW, Nijland MJ, et al. Maternal undernutrition reduces concentrations of amino acids and polyamines in ovine maternal and fetal plasma and fetal fluids. Biolology of Reproduction 2004; 71:901908.
  • 77
    Jobgen WS, Ford SP, Jobgen SC, Feng CP, Hess BW, Nathanielsz PW, et al. Baggs ewes adapt to maternal undernutrition and maintain conceptus growth by maintaining fetal plasma concentrations of amino acids. Journal of Animal Science 2008; 86:820826.
  • 78
    Wallace JM, Luther JS, Milne JS, Aitken RP, Redmer DA, Reynolds LP, et al. Nutritional modulation of adolescent pregnancy outcome – a review. Placenta 2006; 27:S61S68.
  • 79
    Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, et al. Vitamin B-12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51:2938.
  • 80
    Kalra P, Das V, Agarwal A, Kumar M, Ramesh V, Bhatia E, et al. Effect of vitamin D supplementation during pregnancy on neonatal mineral homeostasis and anthropometry of the newborn and infant. British Journal of Nutrition 2012; 3:17. [Epub ahead of print].
  • 81
    Ashworth CJ, Antipatis C. Micronutrient programming of development throughout gestation. Reproduction 2001; 122:527535.
  • 82
    Dror DK, Allen LH. Vitamin D inadequacy in pregnancy: biology, outcomes, and interventions. Nutrition Review 2010; 68:465477.
  • 83
    Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Human Development 2006; 82:485491.
  • 84
    Sloan NL, Lederman SA, Leighton J, Himes JH, Rush D. The effect of prenatal dietary intake on birth weight. Nutrition Research 2001; 21:129139.
  • 85
    Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. American Journal of Clinical Nutrition 2009; 89:668S672S.
  • 86
    Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. American Journal of Respiratory and Critical Care Medicine 2011; 183:13361343.
  • 87
    Jou MY, Philipps AF, Lönnerdal B. Maternal zinc deficiency in rats affects growth and glucose metabolism in the offspring by inducing insulin resistance postnatally. Journal of Nutrition 2010; 140:16211627.
  • 88
    Christian P, Murray-Kolb LE, Khatry SK, Katz J, Schaefer BA, Cole PM, et al. Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA 2010; 304:27162723.
  • 89
    Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, et al. Early nutrition and immunity – progress and perspectives. British Journal of Nutrition 2006; 96:774790.
  • 90
    McDade TW, Beck MA, Kuzawa C, Adair LS. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. American Journal of Clinical Nutrition 2001; 74:543548.
  • 91
    Shah D, Sachdev HP. Zinc deficiency in pregnancy and fetal outcome. Nutrition Review 2006; 64:1530.
  • 92
    Calder PC, Yaqoob P. The level of protein and type of fat in the diet of pregnant rats both affect lymphocyte function in the offspring. Nutrition Research 2000; 20:9951005.
  • 93
    Li P, Yin YL, Li DF, Kim SW, Wu G. Amino acids and immune function. British Journal of Nutrition 2007; 98:237252.
  • 94
    Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Annals of Nutrition and Metabolism 2007; 51:301323.
  • 95
    Uriu-Adams JY, Scherr RE, Lanoue L, Keen CL. Influence of copper on early development: prenatal and postnatal considerations. Biofactors 2010; 36:136152.
  • 96
    Christian P. Micronutrients, birthweight, and survival. Annual Review of Nutrition 2010; 30:83104.
  • 97
    Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. British Journal of Nutrition 2007; 98:S29S35.
  • 98
    Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutrition in Clinical Care 2002; 5:6674.
  • 99
    Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annual Review of Nutrition 2005; 25:151174.
  • 100
    King JC. The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. Journal of Nutrition 2003; 133:1732S1736S.
  • 101
    Wallace JM, Aitken RP, Milne JS, Hay WW Jr. Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biology of Reproduction 2004; 71:10551062.
  • 102
    Gao KG, Jiang ZY, Lin YC, Zheng CT, Zhou GL, Chen F, et al. Dietary L-arginine supplementation enhances placental growth and reproductive performance in sows. Amino Acids 2011. doi: 10.1007/s00726-011-0960-9.
  • 103
    Xiao XM, Li LP. L-arginine treatment for asymmetric fetal growth restriction. International Journal of Gynecology and Obstetrics 2005; 88:1518.
  • 104
    Cetin I, Berti C, Calabrese S. Role of micronutrients in the periconceptional period. Human Reproduction Update 2010; 16:8095.
  • 105
    Osrin D, Vaidya A, Shrestha Y, Baniya RB, Manandhar DS, Adhikari RK, et al. Effects of antenatal multiple micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind, randomised controlled trial. Lancet 2005; 365:955962.
  • 106
    Tan BE, Yin YL, Kong XF, Li P, Li XL, Gao HJ, et al. L-Arginine stimulates proliferation and prevents endotoxin-induced death of intestinal cells. Amino Acids 2010; 38:12271235.
  • 107
    Mateo RD, Wu G, Bazer FW, Park JC, Shinzato I, Kim SW. Dietary L-arginine supplementation enhances the reproductive performance of gilts. Journal of Nutrition 2007; 137:652656.
  • 108
    Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, Li XL, et al. Impacts of amino acid nutrition on pregnancy outcome in pigs: mechanisms and implications for swine production. Journal of Animal Science 2010; 88:E195E204.
  • 109
    Satterfield MC, Bazer FW, Spencer TE, Wu G. Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction. Journal of Nutrition 2010; 140:251258.
  • 110
    Zeng LX, Dibley MJ, Cheng Y, Dang SN, Chang SY, Kong LZ, et al. Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial. BMJ (Clinical Research Ed) 2008; 337:a2001.
  • 111
    Shrimpton R, Huffman SL, Zehner ER, Darnton-Hill I, Dalmiya N. Multiple micronutrient supplementation during pregnancy in developing-country settings: policy and program implications of the results of a meta-analysis. Food and Nutrition Bulletin 2009; 30 (4 Suppl):S556S573.
  • 112
    Lassala A, Bazer FW, Cudd TA, Datta S, Keisler DH, Satterfield MC, et al. Parenteral administration of L-arginine prevents fetal growth restriction in undernourished ewes. Journal of Nutrition 2010; 140:12421248.
  • 113
    Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization 2010; 88:3138.
  • 114
    Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocrine Review 2000; 21:514550.
  • 115
    Petraglia F, Imperatore A, Challis JRG. Neuroendocrine mechanisms in pregnancy and parturition. Endocrine Review 2010; 31:783816.
  • 116
    Dole N, Savitz DA, Hertz-Picciotto I, Siega-Riz AM, McMahon MJ, Buekens P. Maternal stress and preterm birth. American Journal of Epidemiology 2003; 157:1424.
  • 117
    Ahamed M, Mehrotra PK, Kumar P, Siddiqui MKJ. Placental lead-induced oxidative stress and preterm delivery. Environmental Toxicology and Pharmacology 2009; 27:7074.
  • 118
    Dong YL, Dai BS, Singh P, Yallampalli C. Involvement of nitric oxide pathway in prostaglandin F2 alpha-induced preterm labor in rats. American Journal of Obstetrics and Gynecology 1997; 177:907917.
  • 119
    Phillippe M, Saunders T, Basa A. Intracellular mechanisms underlying prostaglandin F2a-stimulated phasic myometrial contractions. American Journal of Physiology Endocrinology and Metabolism 1997; 273:E665E673.
  • 120
    Molnár M, Hertelendy F. Signal transduction in rat myometrial cells: comparison of the actions of endothelin-1, oxytocin and prostaglandin F. European Journal of Endocrinology 1995; 133:467474.
  • 121
    Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004; 127:515526.
  • 122
    Neumann ID. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Progress in Brain Research 2002; 139:147162.
  • 123
    Riopelle AJ, Hale PN. Nutritional and environmental factors affecting gestation length in rhesus monkeys. American Journal of Clinical Nutrition 1975; 28:11701176.
  • 124
    Lenders CM, Hediger ML, Scholl TO, Khoo CS, Slap GB, Stallings VA. Gestational age and infant size at birth are associated with dietary sugar intake among pregnant adolescents. Journal of Nutrition 1997; 127:11131117.
  • 125
    Kramer MS, McLean FH, Eason EL, Usher RH. Maternal nutrition and spontaneous preterm birth. American Journal of Epidemiology 1992; 136:574583.
  • 126
    Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B. Severe obesity, gestational weight gain, and adverse birth outcomes. American Journal of Clinical Nutrition 2010; 91:16421648.
  • 127
    Torheim LE, Ferguson EL, Penrose K, Arimond M. Women in resource-poor settings are at risk of inadequate intakes of multiple micronutrients. Journal of Nutrition 2010; 140:2051S2058S.
  • 128
    Mahomed K, Bhutta Z, Middleton P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews 2007; CD000230.
  • 129
    Siega-Riz AM, Promislow JHE, Savitz DA, Thorp JM, McDonald T. Vitamin C intake and the risk of preterm delivery. American Journal of Obstetrics and Gynecology 2003; 189:519525.
  • 130
    Casanueva E, Ripoll C, Tolentino M, Morales RM, Pfeffer F, Vilchis P, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. American Journal of Clinical Nutrition 2005; 81:859863.
  • 131
    Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicology and Teratology 2005; 27:515524.
  • 132
    Christian P. Maternal nutrition, health, and survival. Nutrition Review 2002; 60:S59S63.
  • 133
    Wehby G, Murray JC. Folic acid and orofacial clefts: a review of the evidence. Oral Disease 2010; 16:1119.
  • 134
    De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, et al. Spina bifida before and after folic acid fortification in Canada. Birth Defects Research A Clinical and Molecular Teratology 2008; 82:622626.
  • 135
    Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics 2005; 116:580586.
  • 136
    Chandra RK. Interactions between early nutrition and the immune system. Ciba Foundation Symposium 1991; 156:7789.
  • 137
    Andersson M, de Benoist B, Rogers L. Epidemiology of iodine deficiency: salt iodisation and iodine status. Best Practice in Research and Clinical Endocrinology and Metabolism 2010; 24:111.
  • 138
    Zimmermann MB. Iodine deficiency. Endocrine Review 2009; 30:376408.
  • 139
    Zimmermann MB. Research on iodine deficiency and goiter in the 19th and early 20th centuries. Journal of Nutrition 2008; 138:20602063.
  • 140
    Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy related maternal mortality. Journal of Nutrition 2001; 131 (2 Suppl 2):604S614S.
  • 141
    Main EK. Maternal mortality: new strategies for measurement and prevention. Current Opinion in Obstetrics and Genecology 2010; 22:511516.
  • 142
    NIH (Washington, DC). High blood pressure in pregnancy. 2011.[Last accessed on October 12, 2011].
  • 143
    Roberts JM. Objective evidence of endothelial dysfunction in preeclampsia. American Journal of Kidney Disease 1999; 33:992997.
  • 144
    Kim YJ, Parks HS, Lee HY, Ha EH, Suh SH, Oh SK, et al. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006; 27:438444.
  • 145
    Rytlewski K, Olszanecki R, Lauterbach R, Grzyb A, Basta A. Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic Clinical Pharmacology and Toxicology 2006; 99:146152.
  • 146
    Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al. Effect of supplementation during pregnancy with arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk populations: randomized controlled trial. BMJ (Clinical Research Ed) 2011; 342:d2901.
  • 147
    Erkkola M, Nwaru BI, Viljakainen HT. Maternal vitamin D during pregnancy and its relation to immune-mediated diseases in the offspring. Vitamins and Hormornes 2011; 86:239260.
  • 148
    Nassar N, Halligan GH, Roberts CL, Morris JM, Ashton AW. Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy. American Journal of Obstetrics and Gynecology 2011; 205:208.e1208.e7.
  • 149
    Weiss ST, Litonjua AA. The in utero effects of maternal vitamin D deficiency: how it results in asthma and other chronic diseases. American Journal of Respiratory and Critical Care Medicine 2011; 15:12861287.
  • 150
    Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999; 354:810816.
  • 151
    Duley L, Henderson-Smart DJ, Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews 2005; (4):CD005548.
  • 152
    World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. WHO/RHR/11.30. Geneva: Food and Agricultural Organization of the United Nations. [Accessed on November 10, 2011].
  • 153
    Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochemical Journal 2011; 437:357372.
  • 154
    McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal state. British Journal of Nutrition 2008; 99 (Suppl 3):S48S54.
  • 155
    Haider BA, Yakoob MY, Bhutta ZA. Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes. BMC Public Health 2011; 11 (Suppl 3):S19.
  • 156
    Lee AI, Okam MM. Anemia in pregnancy. Hematology and Oncology Clinics in North America 2011; 25:241259.
  • 157
    Kavle JA, Stolzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. Association between anemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island. Journal of Health, Population and Nutrition 2008; 26:232240.
  • 158
    Heinonen K, Matilainen R, Koski H, Launiala K. Intrauterine growth retardation in pre-term infants. Journal of Perinatal Medicine 1985; 13:171178.
  • 159
    Gardosi J. Intrauterine growth restriction: new standards for assessing adverse outcome. Best Practice in Research and Clinical Obstetrics and Gynecology 2009; 23:741749.
  • 160
    Barker DJP. Growth and living conditions in childhood and hypertension in adult life: a longitudinal study. Journal of Hypertension 2002; 20:19511956.
  • 161
    Kajantie E, Osmond C, Barker DJP, Forsen T, Phillips DIW, Eriksson JG. Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years. International Journal of Epidemiology 2005; 34:655663.
  • 162
    Lumey LH. Reproductive outcome in women prenatally exposed to undernutrition: a review of findings from the Dutch famine birth cohort. Proceedings of Nutrition Society 1998; 57:129135.
  • 163
    Barker DJP, Clark PM. Fetal undernutrition and disease in later life. Review of Reproduction 1997; 2:105112.
  • 164
    Wang JJ, Wu ZL, Li DF, Li N, Dindot SV, Satterfield MC, et al. Nutrition, epigenetics, and metabolic syndrome. Antioxidants and Redox Signaling 2012. doi: 10.1089/ars.2011.4381.
  • 165
    Youngson NA, Whitelaw E. Transgenerational epigenetic effects. Annual Review of Genomics and Human Genetics 2008; 9:233257.
  • 166
    Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. International Journal of Obesity 2008; 32:13731379.
  • 167
    McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Spencer TE, Meininger CJ, et al. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids 2010; 39:349357.
  • 168
    Wu G, Jaeger LA, Bazer FW, Rhoads JM. Arginine deficiency in premature infants: biochemical mechanisms and nutritional implications. Journal of Nutritional Biochemistry 2004; 15:442451.
  • 169
    Reynolds LP, Caton JS, Redmer DA, Grazul-Bilska AT, Vonnahme KA, Borowicz PB, et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. Journal of Physiology 2006; 572:5158.
  • 170
    Wu X, Ruan Z, Gao YL, Yin YL, Zhou XH, Wang L, et al. Dietary supplementation with L-arginine or N-carbamylglutamate enhances intestinal growth and heat shock protein-70 expression in weanling pigs fed a corn- and soybean meal-based diet. Amino Acids 2010; 39:831839.
  • 171
    Li FN, Yin YL, Tan BE, Kong XF, Wu G. Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids 2011; 41:11851193.
  • 172
    Brown LD, Green AS, Limesand SW, Rozance PJ. Maternal amino acid supplementation for intrauterine growth restriction. Frontiers in Bioscience 2011; S3:428444.